Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50005769
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040737([(7R,13R)-13-(3-Guanidino-propyl)-14-methyl-6,9,12...)
Affinity DataKi:  2.10nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040747((3R,4R,7S,13S,16R)-16-Acetylamino-7-carboxymethyl-...)
Affinity DataKi:  2.10nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040761([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  2.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040737([(7R,13R)-13-(3-Guanidino-propyl)-14-methyl-6,9,12...)
Affinity DataKi:  2.60nMAssay Description:Inhibition of [3H]-SKF- 107260 binding to purified GPIIb/IIIa from human platelets reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040769((7S,13S,16R)-16-Amino-7-carboxymethyl-13-(3-guanid...)
Affinity DataKi:  4.80nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040755((7S,13S,16R)-16-Acetylamino-7-carboxymethyl-13-(3-...)
Affinity DataKi:  8.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040752([(7S,13S,16R)-16-Amino-4-carbamoyl-13-(3-guanidino...)
Affinity DataKi:  9.30nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040742([(11R,17R)-17-(3-Guanidino-propyl)-18-methyl-10,13...)
Affinity DataKi:  9.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040750([(7S,13S,16R)-16-Benzoylamino-4-carbamoyl-13-(3-gu...)
Affinity DataKi:  13.7nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040741([(7R,13S)-13-(3-Guanidino-propyl)-14-methyl-6,9,12...)
Affinity DataKi:  20nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040760([(4S,7R,13R,19S)-19-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  20nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040753([(7S,13S,16R)-4-Carbamoyl-13-(3-guanidino-propyl)-...)
Affinity DataKi:  24.3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040771([(12S,18S)-18-(3-Guanidino-propyl)-19,22-dimethyl-...)
Affinity DataKi:  24.5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040770([(8S,11R,17R)-8-Acetylamino-11-(3-guanidino-propyl...)
Affinity DataKi:  26nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040735([(7S,13S,16R)-4-Carbamoyl-13-(3-guanidino-propyl)-...)
Affinity DataKi:  26nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040756([(7R,13R)-13-(3-Guanidino-propyl)-6,9,12,15-tetrao...)
Affinity DataKi:  27nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040767([(7S,13S,16R)-4-Carbamoyl-13-(3-guanidino-propyl)-...)
Affinity DataKi:  35nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040765([(3S,4R,7S,13S,16R)-16-Acetylamino-4-carbamoyl-13-...)
Affinity DataKi:  45nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040762([(7S,13S,16R)-16-Acetylamino-4-carbamoyl-13-(3-gua...)
Affinity DataKi:  58nMAssay Description:Inhibition of [3H]-SKF- 107260 binding to purified GPIIb/IIIa from human platelets reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040762([(7S,13S,16R)-16-Acetylamino-4-carbamoyl-13-(3-gua...)
Affinity DataKi:  58nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040746([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-14-eth...)
Affinity DataKi:  65nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040740([(4S,7R,13R,19S)-19-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  77nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040774([(4S,7R,13S,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  82nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040764([(4S,7R,13R,16R)-16-(Acetyl-methyl-amino)-4-carbam...)
Affinity DataKi:  110nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040763([(3R,4R,7S,13S,16R)-16-Acetylamino-4-carbamoyl-13-...)
Affinity DataKi:  125nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040773([(4S,7R,13R,19S)-19-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  135nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040775([(12S,18S)-18-(3-Guanidino-propyl)-22-methyl-11,14...)
Affinity DataKi:  143nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040757([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  188nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040758([(8S,11R,17R)-8-Acetylamino-11-(3-guanidino-propyl...)
Affinity DataKi:  280nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040776([(4S,7R,13R,19S)-19-Acetylamino-17-benzyl-4-carbam...)
Affinity DataKi:  430nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040754([(4S,7R,13R,19S)-19-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  610nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040759([(4S,7R,13S,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  720nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50010176(CHEMBL107009 | [16-Acetylamino-4-carbamoyl-13-(3-g...)
Affinity DataKi:  780nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040739(Cyclo-S-S[Mba-P(Ne-Me)RGD-Man] | CHEMBL165211)
Affinity DataKi:  820nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040766([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  1.25E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040768([(4S,7R,13R,16R)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  2.65E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50421884(CHEMBL2110309)
Affinity DataKi:  3.00E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50010174(CHEMBL104534 | 3-[4-amino(imino)methylamino-1-meth...)
Affinity DataKi:  4.20E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040748([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  7.04E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040745([(7S,13R)-13-(3-Guanidino-propyl)-14-methyl-6,9,12...)
Affinity DataKi:  8.75E+3nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040736([(5S,10S,13R,19R,21aS)-5-Acetylamino-10-carbamoyl-...)
Affinity DataKi: >1.00E+4nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040743([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  1.51E+4nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040749([(4S,7R,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi:  2.53E+4nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040738([(4S,7R,13R,16S)-16-Acetylamino-14-benzyl-4-carbam...)
Affinity DataKi: >1.00E+5nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50040751([(4S,7S,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-...)
Affinity DataKi: >1.00E+6nMAssay Description:Tested for inhibition of fibrinogen binding to purified GPIIb/IIIa isolated from human platelets and reconstituted in liposomesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed